entir
human
popul
risk
infecti
diseas
worldwid
thu
far
diagnosi
treatment
human
infecti
diseas
molecular
nanoscal
level
extrem
challeng
task
lack
effect
probe
identifi
recogn
biomark
pathogen
oligonucleotid
aptam
class
small
nucleic
acid
ligand
compos
singlestrand
dna
ssdna
rna
act
affin
probe
molecular
recognit
element
varieti
target
aptam
excit
potenti
diagnos
andor
treatment
specif
diseas
review
highlight
area
aptam
develop
diagnost
therapeut
agent
bacteri
viral
infecti
diseas
well
aptamerbas
detect
infect
pandem
potenti
major
global
risk
infecti
diseas
gener
import
threat
public
health
prevent
control
infecti
diseas
still
associ
multipl
challeng
obstacl
increas
popul
complex
infecti
diseas
lead
synergist
effect
novel
pharmacolog
agent
need
develop
rapid
diagnosi
cut
emerg
infecti
diseas
sourc
explor
novel
molecular
recognit
element
specif
pathogen
key
strategi
develop
antiinfect
agent
new
find
complet
human
genom
sequenc
well
genom
pathogen
ongo
transcriptom
proteom
project
offer
novel
target
fight
infecti
diseas
therefor
necessari
acceler
discoveri
antiinfect
agent
biochem
methodolog
develop
novel
biolog
activ
compound
although
dna
rna
known
import
biolog
macromolecul
respons
encod
transmit
genet
inform
wide
rang
applic
genet
test
molecular
biolog
medicin
oligonucleotid
serv
probe
detect
complementari
dna
rna
target
also
act
affin
probe
molecular
recognit
element
varieti
target
includ
small
molecul
sugar
moieti
lipid
peptid
protein
even
whole
cell
sequenc
individu
clone
altern
recent
year
highthroughput
sequenc
method
bioinformat
analysi
selex
process
sever
counterselect
negativetarget
select
ad
elimin
nonspecif
oligonucleotid
round
select
specif
aptam
bind
target
high
affin
obtain
identifi
nucleic
acidprotein
interact
genom
selex
develop
unlik
randomizedsequ
nucleic
acid
convent
selex
process
start
librari
genom
selex
deriv
genom
organ
interest
wholecel
selex
method
develop
modifi
creat
aptam
bind
live
cell
includ
bacteria
target
wholecel
selex
live
tumor
cell
pathogen
bacteria
aptam
find
effect
bind
surfac
molecul
target
cell
convent
selex
approach
littl
crossreact
nontarget
although
aptam
similar
antibodi
term
affin
specif
target
offer
sever
advantag
antibodi
counterpart
first
aptam
select
vitro
process
depend
anim
cell
even
vivo
condit
antibodi
gener
requir
use
live
anim
stimul
immun
respons
target
molecul
need
immunogen
well
nontox
second
ssdna
aptam
stabl
room
temperatur
wherea
antibodi
requir
refriger
avoid
denatur
third
aptam
shown
low
immunogen
toxic
thu
far
wherea
antibodi
may
evok
neg
immun
respons
final
aptam
small
molecul
may
effect
penetr
tissu
barrier
effect
cell
aptam
excel
nonproteinbas
altern
antibodi
recent
year
aptam
selex
technolog
receiv
much
attent
increasingli
appli
biomed
field
especi
diagnosi
treatment
cancer
infecti
diseas
review
highlight
area
aptam
design
diagnost
therapeut
agent
major
human
infecti
diseas
aptam
target
bacteria
classifi
follow
two
group
target
predefin
bacteria
cell
surfac
antigen
bacteri
virul
factor
b
target
whole
cell
known
unknown
molecular
target
date
studi
antibacteri
aptam
mostli
focus
mycobacterium
tuberculosi
tb
salmonella
listeria
monocytogen
l
monocytogen
staphylococcu
aureu
aureu
escherichia
coli
e
coli
tabl
tuberculosi
tb
lead
caus
death
due
infecti
diseas
worldwid
tradit
diagnost
method
tb
includ
tuberculin
skin
test
tuberculosi
antibodi
detect
microscop
detect
tb
drawback
low
sensit
poor
specif
lengthi
procedur
falseposit
neg
result
bacteri
cultur
gold
standard
clinic
tuberculosi
diagnosi
requir
day
therefor
clear
need
new
agent
strategi
tb
diagnosi
aptam
target
mtb
surfac
lipoglycan
protein
whole
bacteri
cell
gener
potenti
diagnost
tool
select
ssdna
aptam
bind
mannosecap
lipoarabinomannan
manlam
predomin
clinic
epidem
mtb
strain
beij
genotyp
manlam
major
surfac
lipoglycan
tb
immunomodulatori
activ
aptam
detect
manlam
antigen
serum
sputum
sampl
patient
activ
pulmonari
tb
aptb
patient
extrapulmonari
tb
eptb
kda
earli
secret
antigen
target
kda
cultur
filtrat
protein
secret
earli
virul
tb
present
nonvirul
bcg
group
rotherham
et
al
report
ssdna
aptam
ce
protein
aptam
detect
antigen
serum
sampl
patient
aptb
eptb
sputum
sampl
kda
protein
secret
tb
bacteri
growth
also
use
diagnost
target
aptam
qin
et
al
select
ssdna
aptam
protein
tb
develop
ssdna
aptam
antibodi
report
aptam
potenti
serolog
diagnosi
pulmonari
tb
sputum
smearposit
neg
patient
sever
ssdna
aptamerbas
electrochem
biosensor
devis
detect
show
limit
detect
fg
ml
rang
nguban
et
al
demonstr
suitabl
surfac
plasmon
reson
spr
base
selex
identif
two
rna
aptam
bind
tb
esxg
protein
high
affin
esxg
protein
encod
within
locu
tb
secret
system
essenti
optim
growth
pathogen
mycobacteria
lowiron
environ
expect
rna
aptam
would
candid
agent
diagnosi
tb
addit
russel
et
al
gener
slow
offrat
modifi
aptam
somam
subnanomolar
affin
tb
protein
target
evalu
util
direct
antigen
detect
two
group
select
ssdna
aptam
whole
cell
tb
detect
aimaiti
et
al
obtain
speciesspecif
aptam
tb
employ
sandwich
enzymelink
immunosorb
assay
elisa
zhang
et
al
select
ssdna
aptam
whole
cell
tb
immobil
aptam
au
interdigit
electrod
auid
multichannel
seri
piezoelectr
quartz
crystal
mspqc
construct
singlewal
carbon
nanotub
swcnt
aptamerauid
mspqc
sensor
tb
detect
sever
group
conduct
studi
aptam
potenti
therapeut
applic
tb
group
select
sever
aptam
specif
bind
tb
whole
cell
surfac
lipoglycan
first
implement
wholecel
selex
gener
ssdna
aptam
bind
virul
tb
high
affin
specif
select
ssdna
aptam
specif
bind
manlam
virul
tb
strain
significantli
reduc
progress
tb
infect
well
bacteri
load
mice
rhesu
monkey
base
differ
structur
manlam
among
differ
mycobacteria
next
select
ssdna
aptam
specif
bind
manlam
bcg
aptam
act
adjuv
enhanc
immunoprotect
effect
bcg
virul
tb
infect
murin
monkey
model
knowledg
first
report
regard
aptam
serv
adjuv
group
also
report
aptam
potenti
tb
therapi
baig
et
al
identifi
ssdna
aptam
novel
class
potent
inhibitor
tb
acetohydroxyacid
synthas
implic
bacteri
surviv
ranjbar
et
al
design
construct
threedimension
dna
origami
box
base
ssdna
aptam
tuberculosi
treatment
expect
ssdna
aptamerbas
drug
deliveri
system
would
capabl
select
interfac
mtb
would
releas
antitb
drug
near
bacteria
salmonella
salmonella
infect
aris
contamin
food
continu
concern
decad
million
case
salmonella
infect
occur
worldwid
annual
detect
salmonella
contamin
food
consum
therefor
essenti
prevent
measur
public
health
system
joshi
et
al
chose
outermembran
protein
salmonella
typhimurium
typhimurium
select
target
gener
aptam
aptam
conjug
magnet
bead
use
captur
typhimurium
seed
wholecarcass
chicken
rins
sampl
follow
detect
via
quantit
rtpcr
report
colonyform
unit
cfu
success
detect
ml
chicken
rinsat
pulldown
assay
aptam
test
et
al
gener
electrochem
biosensor
salmonella
detect
detect
limit
turn
low
cfuml
aptam
chosen
bagheryan
et
al
develop
labelfre
impedimetr
aptamerbas
biosensor
typhimurium
detect
han
et
al
identifi
rnaseresist
rna
aptam
specif
target
outermembran
protein
c
ompc
typhimurium
select
aptam
specif
bind
typhimurium
gramposit
bacteria
aureu
gramneg
bacteria
e
coli
sever
group
use
wholecel
selex
identifi
ssdna
aptam
bind
typhimurium
salmonella
paratyphi
salmonella
enterica
serovar
enteritidi
enteritidi
salmonella
detect
aptam
bind
whole
cell
salmonella
conjug
nanomateri
gold
nanoparticl
aunp
fluoresc
nanoparticl
probe
magnet
nanoparticl
mnp
concentr
element
load
onto
swcnt
reduc
graphen
oxid
rgo
oh
et
al
immobil
aunpsssdna
aptam
conjug
onto
local
surfac
plasmon
reson
lspr
base
sensor
chip
report
method
detect
typhimurium
spike
pork
meat
sampl
detect
limit
cfuml
hyeon
et
al
test
mixtur
strain
enteritidi
target
obtain
rna
aptam
specif
bind
enteritidi
without
crossreact
salmonella
serovar
potenti
aptam
treatment
salmonella
infect
develop
effect
rna
aptam
call
type
ivb
pili
salmonella
enterica
serovar
typhi
typhi
rna
aptam
inhibit
entri
piliat
typhi
strain
cell
indic
possibl
applic
therapeut
agent
base
et
al
report
potentiometr
biosensor
select
detect
singl
cfu
typhi
suggest
aptam
may
also
appli
typhi
detect
yeom
et
al
develop
aptamerbas
drug
deliveri
system
treatment
typhimurium
infect
system
aunp
conjug
anti
typhimurium
ssdna
aptam
aunpapt
antimicrobi
peptid
amp
load
onto
aunpapt
report
antimicrobi
activ
amp
via
aunpapt
conjug
typhimurium
infect
vitro
vivo
aureu
one
major
human
pathogen
respons
wide
rang
infect
includ
hospitalacquir
one
lifethreaten
infect
addit
bacteria
caus
foodborn
ill
due
excret
sever
enterotoxin
therefor
sever
ssdna
aptam
develop
staphylococc
enterotoxin
se
develop
potenti
diagnost
agent
aptam
apt
staphylococc
enterotoxin
b
seb
aptam
aureu
enterotoxin
aptam
aptam
peptidoglycan
aptam
pa
protein
gener
detect
se
among
aptam
aptam
util
modifi
sandwich
elisa
sensit
detect
nm
atoxin
undilut
human
serum
sampl
achiev
first
ssdna
aptam
specif
whole
cell
aureu
detect
introduc
cao
et
al
obtain
panel
ssdna
aptam
specif
aureu
demonstr
five
aptam
recogn
differ
molecular
target
aureu
strong
affin
k
valu
nanomolar
rang
chosen
borsa
et
al
develop
silica
nanoparticleaptam
conjug
report
assay
success
valid
sens
platform
specif
detect
aureu
cell
concentr
low
cfu
ml
whole
blood
chang
et
al
also
gener
ssdna
aptam
specif
aureu
nanomolar
affin
aptam
conjug
aunp
magnet
bead
respect
use
reson
light
scatter
rl
spectral
assay
report
limit
detect
assay
low
singl
aureu
cell
test
sampl
within
h
employ
wang
et
al
develop
nanosystem
earli
sepsi
diagnosi
nanosystem
capabl
simultan
blood
bacteri
speci
identif
enrich
singl
step
report
success
diagnosi
aureu
infect
mice
mean
nanosystem
studi
conduct
select
aptam
treatment
aureu
infect
aptam
bind
staphylococc
enterotoxin
sea
k
nm
effect
inhibit
seamedi
prolifer
human
peripher
blood
mononuclear
cell
inflammatori
secret
result
indic
aptam
potenti
agent
treatment
aureu
infect
seainduc
diseas
major
caus
aureu
toxic
ssdna
aptam
gener
vivekananda
et
al
report
aptam
significantli
inhibit
cell
death
cytokin
upregul
jurkat
cell
two
research
group
employ
anti
aureu
ssdna
aptam
recognit
element
drug
deliveri
system
kavruk
et
al
design
aptamerg
nanocapsul
specif
target
aureu
control
releas
antibiot
ocsoy
et
al
describ
develop
ssdna
aptamerfunction
gold
nanorod
apt
au
nr
inactiv
methicillinresist
aureu
mrsa
target
phototherm
therapi
ptt
immobil
aptam
onto
au
nr
demonstr
apt
au
nr
act
target
phototherm
agent
select
recogn
effiect
inactiv
mrsa
l
monocytogen
l
monocytogen
foodborn
gramposit
bacterium
caus
listeriosi
seriou
ill
even
caus
death
bacteria
surviv
grow
wide
rang
environment
condit
includ
refriger
temperatur
unit
sate
fda
european
union
implement
zerotoler
polici
toward
l
monocytogen
readytoeat
food
therebi
lead
substanti
effort
develop
highli
sensit
biosensor
foodborn
pathogen
detect
thu
far
antil
monocytogen
aptam
recent
studi
develop
bacteri
detect
ohk
et
al
chose
internalin
invasin
protein
l
monocytogen
target
molecul
gener
ssdna
aptam
alexa
fluor
use
fiberopt
sensor
togeth
antibodi
sandwich
format
detect
l
monocytogen
food
demonstr
detect
cfuml
l
monocytogen
pure
cultur
mixtur
bacteria
well
l
monocytogen
artifici
contamin
initi
inocul
cfu
per
g
readytoeat
meat
product
h
enrich
listeriolysin
llo
cytolysin
express
l
monocytogen
bruno
et
al
develop
ssdna
aptam
call
llo
protein
aptam
appli
fluoresc
enzymelink
dna
aptamermagnet
bead
sandwich
assay
detect
listeria
report
assay
highli
sensit
limit
detect
rang
l
monocytogen
cell
equival
llo
produc
cell
averag
per
sampl
separ
titrat
trial
studi
conduct
gener
ssdna
aptam
whole
cell
l
monocytogen
suh
et
al
report
ssdna
aptam
l
monocytogen
identifi
six
round
posit
two
round
neg
select
ssdna
aptam
bind
affin
l
monocytogen
micromolar
k
valu
weak
bind
affin
nonlisteria
speci
one
aptam
chosen
conjug
magnet
bead
employ
combin
aptam
magnet
captur
amc
qpcr
assay
demonstr
pathogen
could
detect
concentr
cfu
per
buffer
captur
efficaci
one
year
later
suh
et
al
demonstr
develop
new
ssdna
aptam
l
monocytogen
affinitiy
new
ssdna
aptam
improv
k
valu
nanomolar
rang
aptam
specif
l
monocytogen
differ
growth
phase
lee
et
al
adopt
wholecel
selex
strategi
gener
ssdna
aptam
develop
aptamerbas
sandwich
assay
platform
quantif
l
monocytogen
demonstr
platform
yield
linear
respons
wide
concentr
rang
l
monocytogen
cfuml
therebi
facilit
reliabl
detect
bacteria
extrem
low
concentr
e
coli
lot
virul
strain
e
coli
chosen
target
select
specif
aptam
bacteria
found
ubiquit
intestin
flora
anim
human
pathogen
variant
caus
major
public
health
problem
e
coli
caus
sever
sever
ill
human
be
gastrointestin
diseas
bloodi
diarrhea
root
caus
hemolyt
urem
syndrom
bruno
et
al
gener
ssdna
aptam
e
coli
lipopolysaccharid
lp
aptam
use
develop
biosensor
chemiluminesc
color
rapid
detect
amrae
et
al
select
ssdna
aptam
higher
sensit
specif
recognit
wholecel
e
coli
report
bind
affin
aptam
target
bacteria
pm
ssdna
aptam
librari
specif
e
coli
whole
cell
enrich
peng
et
al
e
coli
detect
also
develop
sandwich
detect
system
monoclon
antibodyconjug
magnet
bead
captur
target
bacteria
ssdna
aptam
serv
report
fluoresc
assay
report
aptamerbas
system
detect
bacteria
cfug
sampl
kim
et
al
isol
character
ssdna
aptam
e
coli
kctc
select
use
bacteri
speci
klebsiella
pneumonia
citrobact
freundii
enterobact
aerogen
staphylococcu
epidermidi
counterselect
enhanc
select
ssdna
aptam
target
e
coli
detect
one
aptam
conjug
fluoresc
nanoparticl
afnp
incorpor
optofluid
particlesensor
platform
highthroughput
realtim
singlecel
detect
ecoli
aptam
employ
jin
et
al
develop
detect
platform
base
fluoresc
reson
energi
transfer
fret
rapid
ultrasensit
specif
detect
bacteria
anoth
aptam
e
coli
kctc
call
aptam
appli
labelfre
highli
sensit
electro
chemic
detect
e
coli
basi
roll
circl
amplif
coupl
peroxidasemimick
dnazym
amplif
detect
limit
cfuml
dua
et
al
gener
f
modifi
rna
aptam
wholecel
selex
target
e
coli
develop
aptam
gap
capacit
biosensor
electrochem
imped
spectroscopi
ei
detect
limit
cfuml
e
coli
cell
without
label
signal
amplif
techniqu
render
et
al
conduct
wholecel
selex
select
ssdna
aptam
tyrosinelik
side
chain
live
e
coli
cell
report
aptam
possess
high
select
affin
target
cell
greatli
enrich
phenolmodifi
du
nucleotid
result
highlight
mean
increas
chemic
divers
aptam
afford
high
affin
specif
potenti
challeng
target
report
screen
aptam
potenti
antibacteri
antibiot
agent
infect
virul
e
coli
scarc
dna
aptam
develop
lp
e
coli
bruno
et
al
demonstr
polyclon
antilp
aptam
bind
lp
e
coli
high
affin
aptam
coupl
human
protein
trigger
destruct
e
coli
strain
specif
aptam
target
viral
protein
involv
stage
adsorpt
penetr
replic
matur
even
releas
viral
infect
cycl
current
aptam
report
potenti
applic
tabl
caus
major
hiv
infect
global
hiv
infect
lead
chronic
viral
diseas
eventu
acquir
immunodefici
syndrom
aid
peopl
chronic
infect
may
none
hivrel
symptom
mani
year
therefor
earli
detect
infect
import
hivaid
treatment
hiv
accessori
protein
includ
transactiv
transcript
tat
protein
import
transcript
viral
rna
enhanc
amount
protein
produc
attach
viral
rna
tat
protein
one
promis
candid
hiv
screen
protein
releas
bodi
earli
stage
infect
yamamoto
et
al
first
gener
rna
aptam
specif
tat
protein
aptam
use
develop
biosensor
detect
tat
protein
anoth
research
conduct
rahim
ruslinda
et
al
yield
split
rna
aptam
detect
probe
tat
demonstr
effect
diamondfet
fieldeffect
transistor
base
rna
aptam
detect
real
sampl
tat
protein
concentr
nm
although
combin
antiretrovir
therapi
cart
suppress
viru
stop
progress
diseas
cur
aptam
consid
altern
adjuv
chemic
antivir
agent
cart
aptam
specif
target
variou
part
genom
protein
select
shown
effect
inhibit
viral
fusion
target
cell
suppress
viral
replic
aptam
avail
envelop
glycoprotein
one
rna
aptam
call
block
bind
cell
coreceptor
c
c
chemokin
receptor
type
shorter
variant
modifi
shown
strongli
neutral
infect
anoth
aptam
appli
construct
therapeut
aptamersirna
chimera
chimera
report
show
therapeut
efficaci
infect
vivo
recent
new
potent
ssdna
aptam
bind
obtain
prokofjeva
et
al
demonstr
gquadruplex
form
aptam
fthiobclon
aptam
bclonmut
inhibit
lentivir
transduct
low
nanomolar
rang
thu
consid
develop
microbicid
inhibit
replic
cycl
revers
transcriptas
rt
one
main
drug
target
hivaid
rt
catalyz
convers
singlestrand
genom
viral
rna
doublestrand
provir
dna
turn
integr
host
genom
date
numer
rna
dna
aptam
rt
gener
applic
inhibit
viral
replic
investig
among
antirt
aptam
ssdna
aptam
gener
capillari
electrophoresisselex
fluoroarabinonucleotid
fana
aptam
strongli
bind
rt
low
picomolar
dissoci
constant
besid
antirt
aptam
highli
specif
aptamersthat
target
variou
part
genom
transactivationrespons
tar
rna
element
integras
nucleocapsid
gag
rev
proteinshav
isol
shown
effect
suppress
viral
replic
hcv
hcv
common
caus
chronic
hepat
liver
cirrhosi
hepatocellular
carcinoma
current
approv
hcv
vaccin
aptam
research
diagnosi
treatment
area
initi
stage
inhibit
hcv
initi
attach
host
cell
well
develop
agent
earli
diagnosi
hcv
infect
group
carri
cell
surfaceselex
gener
ssdna
aptam
bind
specif
hcv
surfac
glycoprotein
good
correl
observ
among
hcv
patient
hcv
antigenaptam
assay
assay
hcv
rna
quantiti
hcv
antibodi
detect
addit
aptam
specif
captur
hcv
particl
significantli
inhibit
hcv
cell
cultur
hcvcc
infect
human
hepatocyt
vitro
specul
may
benefici
new
molecular
probe
hcv
detect
well
antihcv
therapi
research
group
report
aptam
hcv
core
c
antigen
hcv
detect
ghanbari
et
al
immobil
antic
antigen
aptam
onto
graphen
quantum
dot
god
aptamergod
place
surfac
glassi
carbon
electrod
demonstr
electrochem
aptamerbas
biosensor
effect
detect
hcv
c
antigen
detect
limit
pgml
aptam
hcv
c
antigen
crucial
earli
diagnosi
hepat
c
within
diagnost
window
period
serum
antibodi
appear
yet
earlier
studi
aptam
antihcv
therapi
effort
focus
develop
novel
aptam
bind
hcv
protein
intern
ribosom
entri
site
ire
protein
possess
proteas
nucleosid
triphosphatas
helicas
activ
hcv
ire
direct
bind
ribosom
close
proxim
start
codon
viral
open
read
frame
aptam
block
activ
ire
expect
inhibit
hcv
replic
translat
hold
promis
antihcv
therapeut
agent
recent
et
al
design
multival
aptam
hcv
genom
report
chimer
rna
aptam
call
ic
valu
nm
simultan
target
hcv
ire
domain
iiif
iv
block
rnadepend
rna
polymeras
nonstructur
protein
anoth
strategi
develop
antihcv
therapeut
aptam
aptam
strongli
inhibit
hcv
polymeras
activ
viral
replic
aptam
suppress
format
infecti
viru
particl
vitro
influenza
virus
caus
respiratori
diseas
bird
mammal
three
major
type
influenza
virus
influenza
b
c
influenza
viru
lead
season
epidem
well
sporad
pandem
influenza
henc
regard
major
caus
acut
infecti
diseas
death
recent
year
influenza
rapid
diagnost
test
becam
avail
diagnost
test
base
detect
influenza
antigen
antibodi
howev
aptam
current
view
equal
better
tool
compar
antibodi
antigen
identif
hemagglutinin
ha
antigen
ubiquit
express
surfac
influenza
virus
serv
major
target
aptam
ha
antigen
also
facilit
first
stage
influenza
viru
infect
bind
speciesspecif
host
cell
respiratori
epithelium
thu
far
aptam
ha
develop
diagnost
purpos
rna
aptam
bind
ha
human
influenza
viru
subtyp
stronger
affin
compar
convent
antiha
monoclon
antibodi
bai
et
al
develop
portabl
spr
aptasensor
aptamerbas
biosensor
base
specif
dna
aptam
rapid
detect
avian
influenza
viru
aiv
total
detect
time
h
faster
convent
method
aiv
detect
viru
isol
identif
day
elisa
h
rtpct
h
wang
et
al
select
ssdna
aptam
ha
aiv
k
valu
aptam
nm
antiha
aptam
later
immobil
onto
gold
interdigit
microelectrod
develop
rapid
detect
method
method
detect
limit
hemagglutin
unit
hau
tracheal
chicken
swab
sampl
spike
viru
aptam
influenza
viru
detect
target
whole
viru
particl
lai
et
al
carri
screen
found
influenza
virusspecif
aptam
later
incorpor
integr
microfluid
chip
detect
limit
detect
found
hau
potenti
therapeut
aptam
kwon
et
al
isol
rna
aptam
specif
glycosyl
receptorbind
domain
ha
protein
demonstr
select
aptam
suppress
viral
attach
host
cell
neutral
receptorbind
site
influenza
viru
ha
yuan
et
al
chose
amino
acid
residu
nterminu
pa
subunit
pa
n
influenza
viru
polymeras
target
select
ssdna
aptam
gener
ssdna
afford
crossprotect
infect
influenza
virus
ic
nm
although
year
sinc
aptam
first
construct
studi
exploit
aptam
mani
viral
diseas
advanc
enough
design
systemat
howev
recent
studi
conduct
aptam
virus
hepat
b
viru
hbv
human
papilloma
viru
hpv
sever
acut
respiratori
syndrom
coronaviru
sarscov
dengu
virus
denv
rabi
viru
among
select
aptam
sever
aptam
target
viral
surfac
antigen
virusinfect
cell
eg
rna
aptam
specif
bind
hbv
surfac
agexpress
hepatoma
cell
ssdna
aptam
target
envelop
protein
ssdna
aptam
target
neurotrop
rabi
viru
rabv
glycoproteinexpress
cell
rabi
virusinfect
cell
aptam
bind
viral
enzym
inhibit
replic
eg
rna
aptam
hbv
polymeras
protein
ssdna
aptam
sarscov
helicas
sever
aptam
target
viral
protein
thu
block
nucleocapsid
format
eg
ssdna
aptam
hbv
core
protein
matrixbind
domain
aptam
target
viral
oncoprotein
eg
rna
aptam
bind
oncoprotein
aptasensor
biosensor
biolog
recognit
element
dna
rna
aptam
recent
year
aptasensor
design
possibl
diagnost
applic
major
detect
method
includ
optic
transduct
b
electrochem
detect
c
mass
sensit
detect
follow
subsect
basic
principl
aptasensorbas
detect
briefli
discuss
optic
transduct
subdivid
three
major
method
absorb
assay
fluoresc
detect
colorimetr
detect
absorb
assay
enzymelink
oligonucleotid
assay
elona
usual
implement
direct
method
elona
plate
coat
target
molecul
cell
biotinyl
aptam
bind
target
follow
addit
streptavidinhors
radish
peroxidas
hrp
conjug
enzym
substrat
color
develop
fig
sandwich
assay
elona
captur
antibodi
aptam
immobil
plate
follow
addit
target
molecul
hrplink
aptam
antibodi
enzym
substrat
principl
fluoresc
detect
measur
fluoresc
signal
gener
quench
aptasensor
bind
target
fig
b
aptam
label
fluorophor
conjug
quantum
dot
qd
chang
fluoresc
signal
detect
target
bound
aptam
sometim
fretbas
technolog
use
aptasensor
fret
process
fluoresc
particl
donor
quencher
particl
acceptor
fluoresc
donor
quench
acceptor
come
close
nm
quencher
usual
attach
complementari
sequenc
aptam
thu
fluoresc
aptam
quench
due
good
overlap
fluoresc
emiss
aptam
absorpt
spectrum
complementari
sequenc
aptam
bind
target
quencher
move
away
fluorophor
owe
conform
chang
aptam
afford
signal
detect
aunp
wide
use
aptasensorbas
colorimetr
assay
aunp
sizeanddistancedepend
optic
featur
welldispers
aunp
solut
red
aggreg
form
aunp
blue
purpl
due
chang
surfac
reson
frequenc
aunp
aptam
modifi
mercapto
group
end
conjug
aunp
au
bond
bind
aptameraunp
conjug
target
caus
aggreg
aunp
result
absorb
spectral
chang
aunp
solut
fig
c
sometim
biotinyl
aptam
combin
streptavidinco
aunp
report
system
system
target
bacteria
captur
captur
antibodi
aptam
biotinyl
aptam
streptavidinco
aunp
ad
develop
color
principl
electrochem
detect
base
motor
chang
electr
properti
aptam
bind
target
one
strategi
detect
coordin
aptam
swcnt
signal
amplif
fig
swcnt
serv
effect
iontoelectron
transduc
extraordinari
abil
promot
electron
transfer
heterogen
phase
swcnt
swcntbase
aptasensor
system
aptam
immobil
swcnt
immobil
aptam
captur
target
bacteria
measur
chang
emerg
conduct
system
swcntaptam
hybrid
materi
allow
charg
transfer
swcnt
solut
interfac
ion
around
target
bacteri
wall
chemic
modifi
graphen
oxid
go
reduc
graphen
oxid
rgo
excel
electrochem
transduct
properti
incorpor
electrochem
aptasensor
enhanc
signal
aptam
coval
noncoval
attach
onto
gorgo
sheet
fig
b
bind
aptam
target
caus
aptam
leav
gorgo
surfac
consequ
chang
electromot
forc
emf
take
place
termin
gorgo
aptasensor
work
electrod
doubl
junction
refer
electrod
separ
negativelycharg
phosphodiest
group
gorgo
surfac
fig
b
aptam
bind
target
quencher
move
away
fluorophor
owe
conform
chang
aptam
afford
signal
detect
c
optic
aunpsbas
aptasensor
nanoparticl
mix
target
bacteria
complex
form
magnet
field
target
bacteria
accumul
chang
absorb
spectrum
detect
fig
electrochem
aptasensor
swcntbase
aptasensor
aptam
immobil
swcnt
immobil
aptam
captur
target
bacteria
measur
chang
emerg
conduct
system
b
gobas
aptasensor
aptam
load
onto
go
sheet
bind
aptam
target
caus
aptam
leav
sheet
surfac
consequ
emf
chang
take
place
mass
sensit
detect
method
pathogen
includ
spr
aptasensor
b
surfac
acoust
wave
saw
aptasensor
c
quartz
crystal
microbal
qcm
aptasensor
detect
system
requir
addit
label
sprbase
system
aptam
usual
label
biotin
immobil
streptavidin
coat
gold
chip
bind
target
aptam
lead
chang
plasmon
reson
plasmon
angl
measur
fig
saw
aptasensor
qcm
aptasensor
acoust
wave
sensor
saw
aptasensor
record
phase
shift
amplitud
chang
due
bind
target
surfaceimmobil
aptam
fig
b
qcm
aptasensor
system
aptam
load
onto
goldcoat
quartz
bind
target
aptam
caus
increas
mass
surfac
crystal
gener
detect
decreas
reson
frequenc
crystal
although
aptam
promis
candid
diagnost
therapeut
applic
challeng
still
remain
vitro
select
vs
vivo
target
aptam
select
vitro
given
structur
target
molecul
divers
complex
vivo
aptam
may
work
vivo
expect
crossbind
nontarget
molecul
may
limit
use
aptam
detect
mani
real
world
complex
sampl
biolog
fluid
food
matric
therefor
care
design
select
process
necessari
improv
specif
identifi
aptam
better
distinguish
close
relat
molecul
low
concentr
high
variat
bacteria
virus
complex
structur
target
addit
factor
may
influenc
perform
aptam
import
continu
develop
simpler
effici
selex
procedur
requir
less
time
select
develop
specif
andor
univers
aptam
variou
bacteri
pathogen
unmodifi
aptam
especi
rna
aptam
gener
suscept
digest
cellular
nucleas
present
bodi
fluid
cell
therefor
chemic
modif
often
introduc
oligonucleotid
increas
vivo
stabil
aptam
chemic
modif
includ
cap
invert
thymidinebiotin
phosphorothioatemethylphosphon
substitut
phosphat
backbon
sugar
modif
fluoro
f
amino
nh
omethyl
och
group
lock
nucleic
acid
lna
modif
lna
modif
intramolecular
c
methylen
bridg
lna
show
high
resist
ribozym
common
modif
substitut
sulfur
atom
nonbridg
oxygen
dna
rna
phosphat
backbon
well
modif
rna
aptam
posit
ribos
ring
modifi
rna
aptam
halflif
rang
sever
hundr
hour
unmodifi
rna
usual
halflif
second
human
serum
small
mass
kda
short
diamet
nm
aptam
easili
filter
glomerular
capillari
extend
circul
time
aptam
conjug
compound
high
molecular
mass
eg
polyethylen
glycol
peg
cholesterol
antibodi
liposom
nanomateri
peg
wide
use
prolong
circul
halflif
biolog
agent
besid
halflif
extens
blood
circul
conjug
peg
improv
drug
solubl
stabil
first
aptamerbas
drug
macugen
base
pegyl
pegyl
aptam
halflif
h
accord
pharmacokinet
experi
perform
rhesu
monkey
last
two
decad
grow
number
studi
aptam
target
pathogen
although
aptam
fungi
report
lot
aptam
specif
target
bacteri
viral
virul
factorsa
well
entir
bacteri
cell
viral
particleshav
gener
exampl
ssdna
aptam
hcvsurfac
glycoprotein
use
sever
report
oligonucleotid
aptam
promis
candid
diagnosi
treatment
infecti
diseas
develop
aptasensor
becom
increasingli
divers
field
aptasensor
dna
rna
aptam
serv
biolog
recognit
element
enzymelink
oligonucleotid
assay
fluoresc
colorimetri
electrochemistri
mass
sensit
popular
readout
format
mani
attract
featur
aptasensor
encourag
research
continu
optim
use
diseas
diagnosi
treatment
increas
number
applic
aptasensor
realm
medicin
may
commerci
futur
aptam
sever
advantag
protein
antibodi
lower
immunogen
easier
product
smaller
size
aptam
antibodi
potenti
serv
diagnost
therapeut
tool
sinc
first
monoclon
antibodi
produc
widespread
distribut
adopt
antibodi
well
welldevelop
infrastructur
led
widespread
applic
antibodi
diseas
diagnosi
howev
aptam
stabl
easier
label
modifi
much
lower
cost
manufactur
compar
antibodi
therapeut
aptam
advantag
antibodi
treatment
antitoxin
antivenom
antimultipl
drug
resist
bacteri
viral
infect
therapeut
effect
safeti
aptam
care
studi
recent
first
report
aptamerspecif
resist
cell
cultur
publish
util
broadspectrum
aptam
medic
treatment
track
longterm
effect
aptam
may
necessari
aptam
field
probabl
touch
tip
iceberg
research
focu
optim
selex
method
aptam
modif
combin
aptam
target
drug
deliveri
aptam
technolog
continu
reveal
promis
featur
vast
diagnost
therapeut
potenti
infecti
diseas
present
futur
author
declar
conflict
interest
